Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+9.46%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$36.7B
AUM Growth
+$5.6B
(+18%)
Cap. Flow
+$3.43B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
25.01%
Holding
1,178
New
48
Increased
837
Reduced
168
Closed
53
Top Buys
| 1 |
Microsoft
MSFT
|
+$236M |
| 2 |
Apple
AAPL
|
+$155M |
| 3 |
PayPal
PYPL
|
+$90.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$82.5M |
| 5 |
Amazon
AMZN
|
+$78.9M |
Top Sells
| 1 |
Amphenol
APH
|
+$45.8M |
| 2 |
Fidelity National Information Services
FIS
|
+$37.8M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$20.6M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$18.1M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$8.6M |
Sector Composition
| 1 | Technology | 24.28% |
| 2 | Healthcare | 19.27% |
| 3 | Financials | 13.41% |
| 4 | Consumer Staples | 8.81% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Olin
OLN
$2.91B
| $310K | ﹤0.01% |
5,912
+1,741
| +42% | +$91.2K |
|
|
CBL
977
CBL Properties
CBL
$990M
| $300K | ﹤0.01% |
12,962
+2,123
| +20% | +$49.1K |
|
|
UHT
978
Universal Health Realty Income Trust
UHT
$571M
| $300K | ﹤0.01% |
6,233
+77
| +1% | +$3.7K |
|
979
Rocket Pharmaceuticals
RCKT
$346M
| $295K | ﹤0.01% |
15,419
-9,786
| -39% | -$188K |
|
980
Sarepta Therapeutics
SRPT
$1.85B
| $295K | ﹤0.01% |
2,366
-1,271
| -35% | -$159K |
|
981
Amicus Therapeutics
FOLD
$2.43B
| $290K | ﹤0.01% |
24,293
-9,649
| -28% | -$115K |
|
|
FPI
982
Farmland Partners
FPI
$473M
| $289K | ﹤0.01% |
23,226
| – | – |
|
983
Leonardo DRS
DRS
$10.7B
| $283K | ﹤0.01% |
+23,311
| New | +$283K |
|
|
GMRE
984
Global Medical REIT
GMRE
$505M
| $282K | ﹤0.01% |
30,002
| – | – |
|
|
CLDT
985
Chatham Lodging
CLDT
$350M
| $282K | ﹤0.01% |
23,963
| – | – |
|
|
LAND
986
Gladstone Land Corp
LAND
$322M
| $281K | ﹤0.01% |
15,174
| – | – |
|
|
UBA
987
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $281K | ﹤0.01% |
14,787
+218
| +1% | +$4.14K |
|
988
Roivant Sciences
ROIV
$9.21B
| $278K | ﹤0.01% |
38,844
-10,871
| -22% | -$77.7K |
|
989
Regenxbio
RGNX
$500M
| $272K | ﹤0.01% |
12,217
-602
| -5% | -$13.4K |
|
990
Cenntro
CENN
$27.7M
| $269K | ﹤0.01% |
67,966
+27,573
| +68% | +$109K |
|
991
Sight Sciences
SGHT
$187M
| $267K | ﹤0.01% |
+21,649
| New | +$267K |
|
|
BFS
992
Saul Centers
BFS
$792M
| $264K | ﹤0.01% |
6,495
+97
| +2% | +$3.95K |
|
993
Arcturus Therapeutics
ARCT
$487M
| $264K | ﹤0.01% |
15,790
+1,875
| +13% | +$31.3K |
|
|
BLUE
994
DELISTED
bluebird bio
BLUE
| $263K | ﹤0.01% |
+1,896
| New | +$263K |
|
|
ALX
995
Alexander's
ALX
$1.21B
| $263K | ﹤0.01% |
1,187
+213
| +22% | +$47.2K |
|
996
uniQure
QURE
$960M
| $261K | ﹤0.01% |
11,957
-6,824
| -36% | -$149K |
|
997
Shell
SHEL
$209B
| $258K | ﹤0.01% |
4,616
+1,261
| +38% | +$70.6K |
|
998
Krystal Biotech
KRYS
$4.09B
| $257K | ﹤0.01% |
3,249
-1,179
| -27% | -$93.4K |
|
999
Worthington Enterprises
WOR
$3.15B
| $256K | ﹤0.01% |
8,443
+1,851
| +28% | +$56.1K |
|
1000
Twist Bioscience
TWST
$1.51B
| $254K | ﹤0.01% |
10,683
+4,050
| +61% | +$96.4K |
|